Health & Life Co., Ltd. (TPEX:1781)
Taiwan · Delayed Price · Currency is TWD 12.05
-0.05 (-0.41%)
Jan 22, 2026, 1:30 PM CST
Health & Life Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 441.84 | 706.39 | 601.17 | 797.54 | 811.88 | 774.16 | Upgrade | |
Revenue Growth (YoY) | -33.17% | 17.50% | -24.62% | -1.77% | 4.87% | 83.81% | Upgrade |
Cost of Revenue | 342.53 | 558.65 | 508.07 | 699.82 | 766.12 | 647.09 | Upgrade |
Gross Profit | 99.31 | 147.74 | 93.11 | 97.73 | 45.76 | 127.06 | Upgrade |
Selling, General & Admin | 124.17 | 126.88 | 116.95 | 125.47 | 119.84 | 122.49 | Upgrade |
Research & Development | 20.19 | 18.35 | 16.16 | 17.34 | 22.81 | 21.33 | Upgrade |
Operating Expenses | 144.33 | 145.24 | 134.17 | 142.11 | 142.65 | 143.84 | Upgrade |
Operating Income | -45.02 | 2.5 | -41.06 | -44.39 | -96.89 | -16.78 | Upgrade |
Interest Expense | -6.1 | -3.38 | -5.27 | -3.14 | -3.08 | -3.13 | Upgrade |
Interest & Investment Income | 4.27 | 2.43 | 2.26 | 0.78 | 1.95 | 0.98 | Upgrade |
Currency Exchange Gain (Loss) | -7.72 | 19.15 | 3.91 | 22.79 | 24.28 | -2.32 | Upgrade |
Other Non Operating Income (Expenses) | 7.46 | 7.65 | 2.6 | 6.96 | -7.56 | 5.61 | Upgrade |
EBT Excluding Unusual Items | -47.11 | 28.35 | -37.57 | -17 | -81.3 | -15.64 | Upgrade |
Gain (Loss) on Sale of Investments | -0.38 | -0.02 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.06 | 0.01 | 1.45 | - | 280.15 | Upgrade |
Legal Settlements | - | - | - | - | -2 | - | Upgrade |
Other Unusual Items | 0 | 0.39 | - | 0.09 | - | - | Upgrade |
Pretax Income | -47.49 | 28.78 | -37.56 | -15.47 | -83.3 | 264.52 | Upgrade |
Income Tax Expense | -1.7 | 4.54 | -4.33 | 2.08 | -20.96 | 58.54 | Upgrade |
Net Income | -45.79 | 24.24 | -33.23 | -17.55 | -62.34 | 205.98 | Upgrade |
Net Income to Common | -45.79 | 24.24 | -33.23 | -17.55 | -62.34 | 205.98 | Upgrade |
Shares Outstanding (Basic) | 47 | 47 | 47 | 47 | 47 | 47 | Upgrade |
Shares Outstanding (Diluted) | 47 | 47 | 47 | 47 | 47 | 48 | Upgrade |
Shares Change (YoY) | - | - | - | - | -0.21% | 0.21% | Upgrade |
EPS (Basic) | -0.97 | 0.51 | -0.70 | -0.37 | -1.31 | 4.34 | Upgrade |
EPS (Diluted) | -1.00 | 0.48 | -0.70 | -0.37 | -1.31 | 4.34 | Upgrade |
Free Cash Flow | 31.64 | 30.25 | 76.94 | -85.44 | -143.53 | -56.72 | Upgrade |
Free Cash Flow Per Share | 0.67 | 0.64 | 1.62 | -1.80 | -3.03 | -1.19 | Upgrade |
Gross Margin | 22.48% | 20.91% | 15.49% | 12.25% | 5.64% | 16.41% | Upgrade |
Operating Margin | -10.19% | 0.35% | -6.83% | -5.56% | -11.93% | -2.17% | Upgrade |
Profit Margin | -10.36% | 3.43% | -5.53% | -2.20% | -7.68% | 26.61% | Upgrade |
Free Cash Flow Margin | 7.16% | 4.28% | 12.80% | -10.71% | -17.68% | -7.33% | Upgrade |
EBITDA | -29.91 | 14.5 | -29.21 | -34.51 | -89.91 | -7.91 | Upgrade |
EBITDA Margin | -6.77% | 2.05% | -4.86% | -4.33% | -11.07% | -1.02% | Upgrade |
D&A For EBITDA | 15.11 | 12.01 | 11.85 | 9.87 | 6.98 | 8.87 | Upgrade |
EBIT | -45.02 | 2.5 | -41.06 | -44.39 | -96.89 | -16.78 | Upgrade |
EBIT Margin | -10.19% | 0.35% | -6.83% | -5.56% | -11.93% | -2.17% | Upgrade |
Effective Tax Rate | - | 15.77% | - | - | - | 22.13% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.